Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000661958 | SCV000784288 | uncertain significance | Ullrich congenital muscular dystrophy | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000661959 | SCV000784289 | uncertain significance | Bethlem myopathy 2 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000691825 | SCV000819618 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2023-11-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144462 | SCV003833322 | uncertain significance | not provided | 2019-10-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003411568 | SCV004113776 | uncertain significance | COL12A1-related disorder | 2023-01-05 | criteria provided, single submitter | clinical testing | The COL12A1 c.2108C>T variant is predicted to result in the amino acid substitution p.Ala703Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.011% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-75890711-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |